S&P 500

5.469,30

0,39%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Menlo Therapeutics Inc (MNLO)
Menlo Therapeutics Inc (MNLO) Notícias

MNLO

Menlo Therapeutics (MNLO)

Menlo Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:MNLO

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
02/06/2023	17:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MNLO	Menlo Therapeutics Inc
11/05/2023	17:25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MNLO	Menlo Therapeutics Inc
11/05/2023	17:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MNLO	Menlo Therapeutics Inc
14/03/2023	18:14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:MNLO	Menlo Therapeutics Inc
25/11/2022	16:01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:MNLO	Menlo Therapeutics Inc
18/11/2022	19:01	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:MNLO	Menlo Therapeutics Inc
14/11/2022	18:51	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:MNLO	Menlo Therapeutics Inc
28/07/2022	17:31	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MNLO	Menlo Therapeutics Inc
12/05/2022	18:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:MNLO	Menlo Therapeutics Inc
15/02/2022	08:40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
14/01/2022	19:22	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
21/06/2021	18:19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MNLO	Menlo Therapeutics Inc
17/05/2021	07:30	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:MNLO	Menlo Therapeutics Inc
06/05/2021	18:03	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:MNLO	Menlo Therapeutics Inc
20/04/2021	17:49	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
04/03/2021	18:32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:MNLO	Menlo Therapeutics Inc
02/02/2021	17:17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MNLO	Menlo Therapeutics Inc
05/06/2020	17:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:MNLO	Menlo Therapeutics Inc
22/05/2020	09:30	Business Wire	Robbins Geller Rudman & Dowd LLP Announce Proposed Settlement in the Menlo Therapeutics Inc. Securities Settlement	NASDAQ:MNLO	Menlo Therapeutics Inc
16/04/2020	13:47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
03/03/2020	18:05	GlobeNewswire Inc.	Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results	NASDAQ:MNLO	Menlo Therapeutics Inc
26/02/2020	09:30	GlobeNewswire Inc.	Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin	NASDAQ:MNLO	Menlo Therapeutics Inc
25/02/2020	21:01	GlobeNewswire Inc.	Menlo Therapeutics to Host Conference Call Tomorrow to Discuss Results from Phase 2 Trial of Serlopitant in Patients with Chr...	NASDAQ:MNLO	Menlo Therapeutics Inc
05/02/2020	10:30	GlobeNewswire Inc.	Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Pso...	NASDAQ:MNLO	Menlo Therapeutics Inc
07/01/2020	18:49	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:MNLO	Menlo Therapeutics Inc
06/01/2020	18:48	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
16/12/2019	19:15	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:MNLO	Menlo Therapeutics Inc
04/12/2019	19:20	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:MNLO	Menlo Therapeutics Inc
27/11/2019	10:00	GlobeNewswire Inc.	Menlo Therapeutics CEO to Participate in Fireside Chat at the Piper Jaffray 31st Annual Healthcare Conference	NASDAQ:MNLO	Menlo Therapeutics Inc
12/11/2019	19:09	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Foamix Pharmaceuticals Ltd.	NASDAQ:MNLO	Menlo Therapeutics Inc